These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8367976)

  • 1. [Association between fibrinogen and blood sedimentation rate in combined extracorporal and fibrinogen reducing drug therapy].
    Walzl M; Walzl B; Schied G; Lechner H
    Wien Klin Wochenschr; 1993; 105(14):404-7. PubMed ID: 8367976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [H.E.L.P. (heparin-induced extracorporeal LDL precipitation) and bezafibrate--a new therapeutic combination in cerebrovascular diseases].
    Walzl M; Walzl B; Kleinert G; Schied H; Lechner H
    Vasa Suppl; 1992; 37():85-7. PubMed ID: 1481114
    [No Abstract]   [Full Text] [Related]  

  • 3. [Heparin-induced extracorporeal LDL precipitation (HELP). A new therapeutic possibility in cerebral multi-infarct dementia].
    Walzl M; Walzl B; Kleinert G; Schied G; Lechner H
    Nervenarzt; 1993 Oct; 64(10):648-52. PubMed ID: 8232678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemorrheology and quality of life in fibrinogen- and lipid-lowering therapy].
    Walzl M; Lechner H; Walzl B; Kleinert G; Schied G; Freidl W; Bertha G
    Schweiz Med Wochenschr; 1993 Oct; 123(40):1875-82. PubMed ID: 8211041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of HELP therapy on acute ischemic stroke and vascular endothelial cell function.
    Xue J; Dong Q; Han X; You H; Gu Y; Lin S
    Ther Apher Dial; 2007 Jun; 11(3):171-6. PubMed ID: 17497997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of heparin-induced extracorporeal low-density lipoprotein precipitation and bezafibrate on hemorheology and clinical symptoms in cerebral multiinfarct disease.
    Walzl M
    Haemostasis; 1993; 23(4):192-202. PubMed ID: 8314169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of bezafibrate in the diet of hypertensive patients with dyslipidemia and hyperfibrinogenemia].
    Vázquez-Chávez C; Salinas-Orozco S; Gómez-Díaz RA; Rosso-Juárez MM; Moreno-Vázquez K; Nissen-Torres T; Argüero-Sánchez R
    Rev Invest Clin; 1998; 50(6):491-6. PubMed ID: 10070221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study). Fluvastatin Alone and in Combination Treatment.
    Cortellaro M; Cofrancesco E; Boschetti C; Cortellaro F; Mancini M; Mariani M; Paoletti R
    Thromb Haemost; 2000 Apr; 83(4):549-53. PubMed ID: 10780315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood rheology changes during bezafibrate treatment.
    Caimi G; Francavilla G; Romano A; Catania A; Santonocito G; Sarno A
    Br J Clin Pract; 1988 Nov; 42(11):456-8. PubMed ID: 3076782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
    Walzl B; Walzl M; Lechner P; Lechner H; Cesnik H
    Wien Med Wochenschr; 1993; 143(22):563-70. PubMed ID: 8154130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Heparin-induced extacorporeal low-density lipoprotein-lipoprotein alpha-fibrinogen precipitation in 36 cases].
    Mo JK; Li YX; Lei D; Wu DH
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):278-9. PubMed ID: 12390791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR
    Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial].
    Suckfüll M; Seidel D; Thiery J; Mazurek B; Jaehne M; Gronemeyer J; Reichel O; Sasama J; Kichigina S; Möller M; Beil FU; Schrameyer-Wernecke A; Kassner U; Koch M; Jaeger B; Osterkorn K; Osterkorn D
    Z Kardiol; 2003; 92(Suppl 3):III59-63. PubMed ID: 14663604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased cerebral perfusion following reduction of fibrinogen and lipid fractions.
    Walzl B; Walzl M; Valetitsch H; Lechner H
    Haemostasis; 1995; 25(3):137-43. PubMed ID: 7607582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary prevention with bezafibrate therapy for the treatment of dyslipidemia: an extended follow-up of the BIP trial.
    Goldenberg I; Benderly M; Goldbourt U;
    J Am Coll Cardiol; 2008 Jan; 51(4):459-65. PubMed ID: 18222357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-Induced extracorporeal low-density lipoprotein precipitation apheresis: a new therapeutic concept in the treatment of sudden hearing loss.
    Suckfüll M
    Ther Apher; 2001 Oct; 5(5):377-83. PubMed ID: 11778923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in myocardial vasoreactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron emission tomography.
    Jaeger BR; Bengel FM; Odaka K; Uberfuhr P; Labarrere CA; Bengsch S; Engelschalk C; Kreuzer E; Reichart B; Schwaiger M; Seidel D
    J Heart Lung Transplant; 2005 Dec; 24(12):2022-30. PubMed ID: 16364844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heparin-induced extracorporeal LDL precipitation (HELP) in therapy refractory hypercholesterolemia and coronary heart disease: effect on clinical and morphological regression of coronary sclerosis].
    Schuff-Werner P
    Z Kardiol; 1997; 86 Suppl 1():57-64. PubMed ID: 9173722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.